FULCRUM THERAPEUTICS, INC. Active Patents
7 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2022-12-20: Application 18085134; Invention MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS; Applicant Fulcrum Therapeutics, Inc.; Status Patented Case.
- 2021-02-18: Application 17178637; Invention MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS; Applicant Fulcrum Therapeutics, Inc.; Status Patented Case.
- 2020-04-24: Application 16858404; Invention MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS; Applicant Fulcrum Therapeutics, Inc.; Status Patented Case.
- 2020-04-03: Application 16753664; Invention USE OF P38 INHIBITORS TO REDUCE EXPRESSION OF DUX4; Applicant Fulcrum Therapeutics, Inc.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-20 | 18085134 | MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS | Fulcrum Therapeutics, Inc. | Patented Case | 2024-10-08 | 12109198 | US20240139163A1 | Ivan Viktorovich Efremov Steven Kazmirski Qingyi Li Lorin A. Thompson III Owen Brendan Wallace Shawn Donald Johnstone Feng Zhou Peter Rahl | United States United States United States United States United States Canada Canada United States | SEAMAN, D MARGARET M |
| 2021-02-18 | 17178637 | MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS | Fulcrum Therapeutics, Inc. | Patented Case | 2023-02-28 | 11590111 | US20220160686A1 | Ivan Viktorovich Efremov Steven Kazmirski Qingyi Li Lorin A. Thompson III Owen Brendan Wallace Shawn Donald Johnstone Feng Zhou Peter Rahl | United States United States United States United States United States Canada Canada United States | SEAMAN, D MARGARET M |
| 2020-04-24 | 16858404 | MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS | Fulcrum Therapeutics, Inc. | Patented Case | 2021-04-13 | 10973805 | US20200360353A1 | Ivan Viktorovich EFREMOV Steven KAZMIRSKI Qingyi LI Lorin A. THOMPSON III Owen Brendan WALLACE Shawn Donald JOHNSTONE Feng ZHOU Peter RAHL | United States United States United States United States United States Canada Canada United States | SEAMAN, D MARGARET M |
| 2020-04-03 | 16753664 | USE OF P38 INHIBITORS TO REDUCE EXPRESSION OF DUX4 | Fulcrum Therapeutics, Inc. | Patented Case | 2022-10-25 | 11479770 | US20200332291A1 | Angela Marie CACACE Luis Gustavo Alejandro ROJAS SOTO Lorin A. THOMPSON III Owen Brendan WALLACE Lucienne V. RONCO Ning SHEN Alan Scott ROBERTSON Aaron Nakwon CHANG | United States United States United States United States United States United States United States United States | ZARA, JANE J |
| 2020-01-21 | 16748217 | P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FOR THE TREATMENT OF FSHD | Fulcrum Therapeutics, Inc. | Patented Case | 2022-04-05 | 11291659 | US20200383963A1 | Angela Marie CACACE Luis Gustavo Alejandro ROJAS SOTO Lorin A. THOMPSON III Owen Brendan WALLACE Lucienne V. RONCO Ning SHEN Alan Scott ROBERTSON Aaron Nakwon CHANG | United States United States United States United States United States United States United States United States | RAO, SAVITHA M |
| 2018-11-19 | 16195361 | P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FOR THE TREATMENT OF FSHD | Fulcrum Therapeutics, Inc. | Patented Case | 2020-01-21 | 10537560 | US20190105312A1 | Angela Marie CACACE Luis Gustavo Alejandro ROJAS SOTO Lorin A. THOMPSON III Owen Brendan WALLACE Lucienne V. Ronco Ning Shen Alan Scott Robertson Aaron Nakwon Chang | United States United States United States United States United States United States United States United States | RAO, SAVITHA M |
| 2018-10-19 | 16166031 | P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FOR THE TREATMENT OF FSHD | Fulcrum Therapeutics, Inc. | Patented Case | 2019-07-09 | 10342786 | US20190105311A1 | Angela Marie CACACE Luis Gustavo Alejandro ROJAS SOTO Lorin A. THOMPSON III Owen Brendan WALLACE Lucienne V. RONCO Ning SHEN Alan Scott ROBERTSON Aaron Nakwon CHANG | United States United States United States United States United States United States United States United States | RAO, SAVITHA M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |